Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications

被引:62
作者
Hahl, J
Hämäläinen, H
Sintonen, H
Simell, T
Arinen, S
Simell, O
机构
[1] Turku Sch Econ & Business Adm, Dept Econ, Turku, Finland
[2] Social Insurance Adm, Ctr Res & Dev, Turku, Finland
[3] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[4] Univ Turku, Dept Pediat, Turku, Finland
[5] Natl Publ Hlth Inst, Helsinki, Finland
关键词
Health-Related Quality of Life; multi-attribute; symptom impact; type; 1; diabetes; utility;
D O I
10.1023/A:1015684100227
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To measure subjective health-related quality of life (HRQoL) of patients with type 1 diabetes and describe the influence of symptoms of diabetes-related long-term complications on HRQoL. Methods: The 15-D health-related quality of life measure (15D) was used to measure HRQoL of a representative sample of Finnish insulin-treated patients expected to have type 1 diabetes. Background data were gathered with a separate questionnaire. A tobit (censored regression) model was constructed to estimate the effects of symptoms of complications on HRQoL and to separate these effects from those of other health problems and aging. Results: The 15D scores declined markedly with increasing age, and the prevalence of symptoms of long-term complications increased. The tobit regression model showed that these symptoms have a significant negative influence on HRQoL. The model explained over 50% of the variation in the 15D scores. Conclusions: High prevalence of symptoms of long-term complications combined with their significant negative influence on HRQoL causes substantial losses in terms of quality of life and utility from both individual and societal perspectives. Thus, the importance of secondary prevention, i.e., prevention of complications by better metabolic control, and also the so-far theoretic possibility to prevent type 1 diabetes itself is emphasized.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 59 条
[1]   Health related quality of life among insulin-dependent diabetics: Disease-related and psychosocial correlates [J].
Aalto, AM ;
Uutela, A ;
Aro, AR .
PATIENT EDUCATION AND COUNSELING, 1997, 30 (03) :215-225
[2]  
ARINEN S, 1998, HLTH USE HLTH SERVIC
[3]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[4]   MORTALITY OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN DENMARK - A STUDY OF RELATIVE MORTALITY IN 2930 DANISH TYPE-1 DIABETIC-PATIENTS DIAGNOSED FROM 1933 TO 1972 [J].
BORCHJOHNSEN, K ;
KREINER, S ;
DECKERT, T .
DIABETOLOGIA, 1986, 29 (11) :767-772
[5]   Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes [J].
Bott, U ;
Mühlhauser, I ;
Overmann, H ;
Berger, M .
DIABETES CARE, 1998, 21 (05) :757-769
[6]   The development of an instrument for assessing the quality of life of people with diabetes - Diabetes-39 [J].
Boyer, JG ;
Earp, JAL .
MEDICAL CARE, 1997, 35 (05) :440-453
[7]   DEVELOPING MULTIATTRIBUTE HEALTH INDEXES [J].
BOYLE, MH ;
TORRANCE, GW .
MEDICAL CARE, 1984, 22 (11) :1045-1057
[8]   The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL [J].
Bradley, C ;
Todd, C ;
Gorton, T ;
Symonds, E ;
Martin, A ;
Plowright, R .
QUALITY OF LIFE RESEARCH, 1999, 8 (1-2) :79-91
[9]  
BRAZIER J, 1999, REV USE HLTH STATUS, P3
[10]  
Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195